medRxiv PreprintsInternational2 November 2026
Evaluation of inter-observer agreement for periportal fibrosis related to Schistosoma mansoni: A population-based study of 3302 individuals using point-of-care ultrasound images and video in the SchistoTrack cohort
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Background: Schistosomiasis-related periportal fibrosis (PPF) diagnoses rely on point-of-care ultrasound imaging. Yet, the extent of agreement between sonographers, limitations of existing World Health Organization (WHO) protocols, and the applicability of ultrasound video remain poorly understood. Methods: In 2024, six sonographers performed ultrasound scans for 3302 participants aged 5-92 years within SchistoTrack, a community-based cohort in rural Uganda. We adapted and standardised the WHO Niamey protocol for the collection of curated ultrasound images of liver fibrosis patterns related to
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Individualised and Time-Dependent Prediction of Recurrence After Colorectal Cancer Liver Metastases Resection6 November 2026
- Beyond Perinatal Mood: Breadth of Psychiatric Symptoms and Delay Discounting as Correlates of Mothers' Relational Reports from Pregnancy Through Adult Children6 November 2026
- Brainstem functional connectivity integrates microbiome-gut-brain signals in healthy older adults: a cross-sectional evaluation and a randomised controlled probiotic trial6 November 2026
- Effect of results-based financing on selected maternal and child health indicators in Mayuge District, Uganda: a comparative interrupted time series analysis6 November 2026
- Multidimensional deprivation and brain health in older adults in rural northern Tanzania: a cross-sectional community-based study6 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.